The Food and Drug Administration in August 2006 approved the first generic version of Effexor (venlafaxine), a dual-action norepinephrine/serotonin reuptake inhibitor, for the treatment of major depression.  This is welcome news for people with serious depression who do not have health insurance or pharmacy benefit plans.  In some clinical studies venlafaxine has been shown to [...]